CoChat

The mitotic kinase Aurora-A promotes distant metastases by inducing epithelial-to-mesenchymal transition in ERα+ breast cancer cells

Open access
D'Assoro, A B, liu, T, Quatraro, C, Amato, A, Opyrchal, M, Leontovich, A, Ikeda, Y, Ohmine, S, Lingle, W, Suman, V, Ecsedy, J, Iankov, I, Di Leonardo, A, Ayers-Inglers, J, Degnim, A, Billadeau, D, McCubrey, J, Ingle, J, Salisbury, J L, Galanis, E · 2014 · Oncogene
Cited by 127

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

In this study, we demonstrate that constitutive activation of Raf-1 oncogenic signaling induces stabilization and accumulation of Aurora-A mitotic kinase that ultimately drives the transition from an epithelial to a highly invasive mesenchymal phenotype in estrogen receptor α-positive (ERα+) breast cancer cells. The transition from an epithelial- to a mesenchymal-like phenotype was characterized by reduced expression of ERα, HER-2/Neu overexpression and loss of CD24 surface receptor (CD24−/low). Importantly, expression of key epithelial-to-mesenchymal transition (EMT) markers and upregulation of the stemness gene SOX2 was linked to acquisition of stem cell-like properties such as the ability to form mammospheres in vitro and tumor self-renewal in vivo. Moreover, aberrant Aurora-A kinase activity induced phosphorylation and nuclear translocation of SMAD5, indicating a novel interplay between Aurora-A and SMAD5 signaling pathways in the development of EMT, stemness and ultimately tumor progression. Importantly, pharmacological and molecular inhibition of Aurora-A kinase activity restored a CD24+ epithelial phenotype that was coupled to ERα expression, downregulation of HER-2/Neu, inhibition of EMT and impaired self-renewal ability, resulting in the suppression of distant metastases. Taken together, our findings show for the first time the causal role of Aurora-A kinase in the activation of EMT pathway responsible for the development of distant metastases in ERα+ breast cancer cells. Moreover, this study has important translational implications because it highlights the mitotic kinase Aurora-A as a novel promising therapeutic target to selectively eliminate highly invasive cancer cells and improve the disease-free and overall survival of ERα+ breast cancer patients resistant to conventional endocrine therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/onc.2012.628

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 127

Metadata

Authors
D'Assoro, A. B., liu, T., Quatraro, C., Amato, A., Opyrchal, M., Leontovich, A., Ikeda, Y., Ohmine, S., Lingle, W., Suman, V, Ecsedy, J., Iankov, I., Di Leonardo, A., Ayers-Inglers, J., Degnim, A., Billadeau, D., McCubrey, J., Ingle, J., Salisbury, J. L., & Galanis, E.
Venue
Oncogene
Published
2013-01-21
Volume
33
Issue
5
Pages
599-610
ISSN
  • 0950-9232 (ISSN-L)
  • 1476-5594
OpenAlex
W2049876223
Cited by
127
References
3
FWCI
6.17
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The mitotic kinase Aurora-A promotes distant metastases by inducing epithelial-to-mesenchymal transition in ERα+ breast cancer cells. https://app.cochat.ai/papers/10.1038/onc.2012.628
The paper
D'Assoro, A. B., liu, T., Quatraro, C., Amato, A., Opyrchal, M., Leontovich, A., Ikeda, Y., Ohmine, S., Lingle, W., Suman, V, Ecsedy, J., Iankov, I., Di Leonardo, A., Ayers-Inglers, J., Degnim, A., Billadeau, D., McCubrey, J., Ingle, J., Salisbury, J. L., & Galanis, E. (2014). The mitotic kinase Aurora-A promotes distant metastases by inducing epithelial-to-mesenchymal transition in ERα+ breast cancer cells. Oncogene. https://doi.org/10.1038/onc.2012.628

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.